77 related articles for article (PubMed ID: 2241110)
21. Detection of genes with potential of suppressing transforming activity of the v-Ki-ras oncogene.
Noda M; Ikawa Y
Princess Takamatsu Symp; 1986; 17():261-7. PubMed ID: 3332014
[TBL] [Abstract][Full Text] [Related]
22. [A study on reversion of the human activated c-Ha-ras-transformed cells].
Ogiso Y
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
[TBL] [Abstract][Full Text] [Related]
23. Intracellular expression of the monoclonal anti-ras antibody Y13-259 blocks the transforming activity of ras oncogenes.
Montano X; Jimenez A
Cell Growth Differ; 1995 May; 6(5):597-605. PubMed ID: 7647040
[TBL] [Abstract][Full Text] [Related]
24. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
Koskinen PJ; Ayer DE; Eisenman RN
Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
[TBL] [Abstract][Full Text] [Related]
25. c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype.
Sadhu DN; Lundberg MS; Burghardt RC; Ramos KS
J Cell Physiol; 1994 Dec; 161(3):490-500. PubMed ID: 7962130
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
[TBL] [Abstract][Full Text] [Related]
27. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
28. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
Dartsch PC; Ritter M; Häussinger D; Lang F
Eur J Cell Biol; 1994 Apr; 63(2):316-25. PubMed ID: 8082656
[TBL] [Abstract][Full Text] [Related]
29. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
30. Neoplastic transformation of human cells in vitro.
Rhim JS
Crit Rev Oncog; 1993; 4(3):313-35. PubMed ID: 8485202
[TBL] [Abstract][Full Text] [Related]
31. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
[TBL] [Abstract][Full Text] [Related]
32. The enhanced transfer of drug-resistant genes in NIH-3T3 cells transformed by the EJras oncogene.
Wong D; Liu E; Cadman E
Yale J Biol Med; 1988; 61(1):1-10. PubMed ID: 3284209
[TBL] [Abstract][Full Text] [Related]
33. [Integration of DNA oscillatory vector pSV neo to genome of NIH3T3: importance in investigations of transformation with c-Ha-ras oncogene].
Burzyński A; Wiśniewski R; Wojciechowski W; Porwit-Bóbr Z
Med Dosw Mikrobiol; 1994; 46(1-2):35-41. PubMed ID: 7967925
[TBL] [Abstract][Full Text] [Related]
34. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
Zhao J; Buick RN
Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
[TBL] [Abstract][Full Text] [Related]
35. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
36. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of c-Ras upon transformation, adipocytic differentiation, and apoptosis mediated by the simian virus 40 large tumor antigen.
Cao J; Arulanandam R; Vultur A; Anagnostopoulou A; Raptis L
Biochem Cell Biol; 2007 Feb; 85(1):32-48. PubMed ID: 17464343
[TBL] [Abstract][Full Text] [Related]
38. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms of malignant conversion in skin carcinogenesis.
Yuspa SH; Greenhalgh DA
Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
[TBL] [Abstract][Full Text] [Related]
40. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
Gallagher AP; Burnett AK; Bowen DT; Darley RL
Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
